☆ 4.7 Article

Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions

BLOOD (2004)

Rate this paper

The primary rating indicates the level of overall quality for the paper. Secondary ratings independently reflect strengths or weaknesses of the paper.

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions

Rate this paper

Find the ideal target journal for your manuscript

Become a Peeref-certified reviewer

Export Citation

Share Paper